ArticleCancer chemotherapy and pharmacology2024

Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study.

Nobuaki Matsubara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.